Hi, what are you looking for?
– – Please help us out : Will you offer us a hand? Every gift, regardless of size, fuels our future. Your critical contribution...
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...
– – Eyal Ofer is the richest Israeli, with a fortune of $6.7 billion, followed by his brother, Idan Ofer, with a fortune of...
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– Some of the company’s Israeli shareholders having been cashing in on the share’s record price. – David Reis CEO Stratasys – The share...
– Dan Propper, Chairman of the Israeli Osem Group of companies has sold the last of his shares to Swiss company Nestlé. The...
– The network security company’s main patents are about to expire. – Check Point’s founder, chairman and CEO Gil Shwed – / By Shmulik Shelach...